Ketorolac tromethamine
Ketorolac tromethamine structure
|
Common Name | Ketorolac tromethamine | ||
|---|---|---|---|---|
| CAS Number | 74103-07-4 | Molecular Weight | 376.404 | |
| Density | N/A | Boiling Point | 493.2ºC at 760 mmHg | |
| Molecular Formula | C19H24N2O6 | Melting Point | 160-161ºC | |
| MSDS | Chinese USA | Flash Point | 252.1ºC | |
| Symbol |
GHS06 |
Signal Word | Danger | |
|
Topical cyclosporine a 1% for the treatment of chronic ocular surface inflammation.
Eye Contact Lens 40(5) , 283-8, (2014) To evaluate the use of topical cyclosporine A (CsA) 1% emulsion in the treatment of chronic ocular surface inflammation (OSI).We conducted a retrospective chart review of patients with various forms of OSI treated with topical CsA 1% from 2001 to 2012.Twenty-... |
|
|
Ketorolac eye drops reduce inflammation and delay re-epithelization in response to corneal alkali burn in rabbits, without affecting iNOS or MMP-9.
Arq. Bras. Oftalmol. 78 , 67-72, (2015) To assess the effects of 0.5% ketorolac tromethamine without preservatives on the expression of iNOS and MMP-9 in alkali burn ulcers.Twelve eyes of 120-day-old male rabbits were treated (TG) every 6 h with 0.5% ketorolac tromethamine and 12 other eyes were tr... |
|
|
Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals.
Pharmacotherapy 10(6 ( Pt 2)) , 33S-39S, (1990) In humans, ketorolac is completely bioavailable and its kinetics are linear. It is absorbed rapidly (half-life for absorption 3.8 min) after oral (fasting) and intramuscular administration; food delays but does not reduce its absorption. The drug is highly pr... |
|
|
Ketorolac tromethamine: an oral/injectable nonsteroidal anti-inflammatory for postoperative pain control.
J. Oral Maxillofac. Surg. 50(12) , 1310-3, (1992) Ketorolac tromethamine is a new injectable/oral nonsteroidal anti-inflammatory analgesic with no apparent opiate receptor activity that has been administered alone and in combination with other opiate analgesics for the treatment of postoperative pain. The dr... |
|
|
Clinical pharmacokinetics of ketorolac tromethamine.
Clin. Pharmacokinet. 23(6) , 415-27, (1992) Ketorolac is a new chiral nonsteroidal anti-inflammatory drug (NSAID) which is marketed for analgesia as the racemate. The drug is administered as the water soluble tromethamine salt and is available in tablets or as an intramuscular injection. The absorption... |
|
|
Morphine sulfate, transdermal fentanyl citrate and ketorolac tromethamine: effects on postoperative pulmonary function.
Am. J. Crit. Care 2(1) , 61-4, (1993) The physiological effects of morphine sulfate and fentanyl citrate on postoperative pulmonary function demonstrate varying degrees of respiratory depression related to dose, route of administration and pre-existing pathologies. Current postoperative analgesic... |
|
|
[Ketorolac tromethamine--with special reference to postoperative pain therapy].
Ugeskr. Laeg. 156(8) , 1160-3, (1994)
|
|
|
Ketorolac tromethamine.
Conn. Med. 55(5) , 288-90, (1991)
|
|
|
Cystoid macular oedema following Descemet membrane endothelial keratoplasty.
Br. J. Ophthalmol. 99(1) , 98-102, (2015) To determine the incidence and potential risk factors of cystoid macular oedema (CMO) following Descemet membrane endothelial keratoplasty (DMEK) with or without simultaneous cataract surgery.In this study, 155 eyes of 88 patients suffering from Fuchs endothe... |
|
|
Management of fingolimod-associated macular edema.
JAMA Ophthalmol. 131(5) , 694-6, (2013)
|